MSC-Exosomes are tiny vesicles released by mesenchymal stem cells (MSCs), containing bioactive molecules like proteins, lipids, nucleic acids, and growth factors.

Derived from MSCs, MSC-Exosomes vary in size and composition. While MSCs are living cells with differentiation potential, MSC-Exosomes are small vesicles that convey bioactive molecules for intercellular communication and tissue regeneration.

MSC-Exosomes are isolated from MSC culture media or body fluids, like blood or urine, using centrifugation, filtration, and purification techniques to obtain a concentrated exosome sample.

MSC-Exosomes exhibit therapeutic potential in tissue regeneration, immune and neurological disorders, and oncology by promoting tissue repair, modulating immune responses, enhancing neuronal survival, and delivering therapeutic cargo.

Generally considered safe due to low immunogenicity and non-tumorigenic properties, MSC-Exosomes show minimal adverse effects in preclinical and early clinical studies. Ongoing research and trials aim to establish long-term safety.

Yes, MSC-Exosomes are suitable for allogeneic therapies, with low immunogenicity reducing the risk of rejection. This allows for the development of off-the-shelf therapeutic products.

By transferring cargo like proteins and nucleic acids to recipient cells, MSC-Exosomes modulate cellular functions, promoting tissue regeneration, suppressing inflammation, and regulating immune responses.

Healing effects typically last up to a year, with sustained results for over two years in individuals following an active lifestyle, anti-inflammatory diet, and lifestyle adjustments.

Stem cell therapy usually yields measurable results within 3-6 months, with some experiencing benefits in the initial weeks, depending on the treated area. Each patient responds uniquely to treatment.

Regulatory approvals for MSC-Exosomes therapy vary by country and indication. Consultation with healthcare professionals and regulatory authorities is crucial for updated information on approvals and guidelines.

A course of MSC-Exosomes therapy ranges from RM 3800 to RM 11000, depending on the treatment area, the number of sessions, and case complexity.